Interestingly, LOX transgenesis also exacerbates Ang II-induced cardiac hypertrophy and systolic dysfunction, enhancing inflammation and ROS production and altering Ang II-dependent signaling. The gene discussed is AGT; the disease is cardiac hypertrophy.